These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17284482)

  • 1. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function.
    Chiellini G; Frascarelli S; Ghelardoni S; Carnicelli V; Tobias SC; DeBarber A; Brogioni S; Ronca-Testoni S; Cerbai E; Grandy DK; Scanlan TS; Zucchi R
    FASEB J; 2007 May; 21(7):1597-608. PubMed ID: 17284482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors.
    Frascarelli S; Ghelardoni S; Chiellini G; Vargiu R; Ronca-Testoni S; Scanlan TS; Grandy DK; Zucchi R
    Eur J Pharmacol; 2008 Jun; 587(1-3):231-6. PubMed ID: 18486124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and cardiac metabolism of 3-iodothyronamine.
    Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R
    Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity.
    Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N
    Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors.
    Laurino A; Matucci R; Vistoli G; Raimondi L
    Eur J Pharmacol; 2016 Dec; 793():35-42. PubMed ID: 27815171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.
    Landucci E; Gencarelli M; Mazzantini C; Laurino A; Pellegrini-Giampietro DE; Raimondi L
    Neurochem Int; 2019 Oct; 129():104460. PubMed ID: 31075293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
    Warnecke C; Kaup D; Marienfeld U; Poller W; Yankah C; Gräfe M; Fleck E; Regitz-Zagrosek V
    J Mol Med (Berl); 2001 Sep; 79(9):510-21. PubMed ID: 11692164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors.
    Biebermann H; Kleinau G
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):395-400. PubMed ID: 31698479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5.
    Dinter J; Mühlhaus J; Wienchol CL; Yi CX; Nürnberg D; Morin S; Grüters A; Köhrle J; Schöneberg T; Tschöp M; Krude H; Kleinau G; Biebermann H
    PLoS One; 2015; 10(2):e0117774. PubMed ID: 25706283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors.
    Chiellini G; Erba P; Carnicelli V; Manfredi C; Frascarelli S; Ghelardoni S; Mariani G; Zucchi R
    J Endocrinol; 2012 Jun; 213(3):223-30. PubMed ID: 22442117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and metabolic effects of 3-iodothyronamine in hepatocytes.
    Ghelardoni S; Chiellini G; Frascarelli S; Saba A; Zucchi R
    J Endocrinol; 2014 Apr; 221(1):101-10. PubMed ID: 24627446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.
    Dinter J; Mühlhaus J; Jacobi SF; Wienchol CL; Cöster M; Meister J; Hoefig CS; Müller A; Köhrle J; Grüters A; Krude H; Mittag J; Schöneberg T; Kleinau G; Biebermann H
    J Mol Endocrinol; 2015 Jun; 54(3):205-16. PubMed ID: 25878061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine.
    Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L
    Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern.
    Mariotti V; Melissari E; Iofrida C; Righi M; Di Russo M; Donzelli R; Saba A; Frascarelli S; Chiellini G; Zucchi R; Pellegrini S
    PLoS One; 2014; 9(11):e106923. PubMed ID: 25379707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Iodothyronamine and 3,5,3'-triiodo-L-thyronine reduce SIRT1 protein expression in the HepG2 cell line.
    Sacripanti G; Lorenzini L; Bandini L; Frascarelli S; Zucchi R; Ghelardoni S
    Horm Mol Biol Clin Investig; 2020 Mar; 41(1):. PubMed ID: 32114521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
    Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
    Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 3-iodothyronamine (3-T
    Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial impact of 3-iodothyronamine (T1AM) on the regulations of fluorescent thermoprobe-measured cellular temperature and natriuretic peptide expression in cardiomyocytes.
    Takahashi H; Nagoshi T; Kimura H; Tanaka Y; Yasutake R; Oi Y; Yoshii A; Tanaka TD; Kashiwagi Y; Yoshimura M
    Sci Rep; 2022 Jul; 12(1):12740. PubMed ID: 35882940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction.
    Weil J; Zolk O; Griepentrog J; Wenzel U; Zimmermann WH; Eschenhagen T
    Cardiovasc Res; 2006 Feb; 69(2):412-22. PubMed ID: 16376326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.